Industry Research Reports

Home > Reports > Service & Software > Global Thyroid Cancer Diagnostic Market Research Report 2024

Global Thyroid Cancer Diagnostic Market Research Report 2024

Industry: Service & Software

Published: 2024-02-07

Pages: 78 Pages

Report ld: 2452676

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Thyroid cancer is a type of cancer that occurs when abnormal cell begin to grow in thyroid gland, responsible for the excretion of thyroid hormones. It is asymptotic in early stage and progresses with formation of lump in thyroid gland. If diagnosed in early stage it can be treated easily.

The global Thyroid Cancer Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Thyroid Cancer Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thyroid Cancer Diagnostic.

Report Scope
The Thyroid Cancer Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thyroid Cancer Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Thyroid Cancer Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Report Metric
Details
Report Title
Global Thyroid Cancer Diagnostic Market Research Report 2024
Global Thyroid Cancer Diagnostic Companies Covered
Abbott, Roche, Thermo Fisher Scientific, Siemens Healthcare GmbH, Bio-Rad Laboratories, General Electric, Koninklijke Philips, Agilent Technologies, Illumina
Global Thyroid Cancer Diagnostic Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Thyroid Cancer Diagnostic Market, Segment by Type
Papillary Carcinoma

Follicular Carcinoma

Others
Global Thyroid Cancer Diagnostic Market, Segment by Application
Hospital Laboratories

Cancer Diagnostic Centers

Research Institutes

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Thyroid Cancer Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Table of Contents

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Thyroid Cancer Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
        1.2.2 Papillary Carcinoma
        1.2.3 Follicular Carcinoma
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Thyroid Cancer Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
        1.3.2 Hospital Laboratories
        1.3.3 Cancer Diagnostic Centers
        1.3.4 Research Institutes
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Thyroid Cancer Diagnostic Market Perspective (2019-2030)
    2.2 Thyroid Cancer Diagnostic Growth Trends by Region
        2.2.1 Global Thyroid Cancer Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 Thyroid Cancer Diagnostic Historic Market Size by Region (2019-2024)
        2.2.3 Thyroid Cancer Diagnostic Forecasted Market Size by Region (2025-2030)
    2.3 Thyroid Cancer Diagnostic Market Dynamics
        2.3.1 Thyroid Cancer Diagnostic Industry Trends
        2.3.2 Thyroid Cancer Diagnostic Market Drivers
        2.3.3 Thyroid Cancer Diagnostic Market Challenges
        2.3.4 Thyroid Cancer Diagnostic Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Thyroid Cancer Diagnostic Players by Revenue
        3.1.1 Global Top Thyroid Cancer Diagnostic Players by Revenue (2019-2024)
        3.1.2 Global Thyroid Cancer Diagnostic Revenue Market Share by Players (2019-2024)
    3.2 Global Thyroid Cancer Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Thyroid Cancer Diagnostic Revenue
    3.4 Global Thyroid Cancer Diagnostic Market Concentration Ratio
        3.4.1 Global Thyroid Cancer Diagnostic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Thyroid Cancer Diagnostic Revenue in 2023
    3.5 Thyroid Cancer Diagnostic Key Players Head office and Area Served
    3.6 Key Players Thyroid Cancer Diagnostic Product Solution and Service
    3.7 Date of Enter into Thyroid Cancer Diagnostic Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Thyroid Cancer Diagnostic Breakdown Data by Type
    4.1 Global Thyroid Cancer Diagnostic Historic Market Size by Type (2019-2024)
    4.2 Global Thyroid Cancer Diagnostic Forecasted Market Size by Type (2025-2030)

 5 Thyroid Cancer Diagnostic Breakdown Data by Application
    5.1 Global Thyroid Cancer Diagnostic Historic Market Size by Application (2019-2024)
    5.2 Global Thyroid Cancer Diagnostic Forecasted Market Size by Application (2025-2030)

 6 North America
    6.1 North America Thyroid Cancer Diagnostic Market Size (2019-2030)
    6.2 North America Thyroid Cancer Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
    6.3 North America Thyroid Cancer Diagnostic Market Size by Country (2019-2024)
    6.4 North America Thyroid Cancer Diagnostic Market Size by Country (2025-2030)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Thyroid Cancer Diagnostic Market Size (2019-2030)
    7.2 Europe Thyroid Cancer Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
    7.3 Europe Thyroid Cancer Diagnostic Market Size by Country (2019-2024)
    7.4 Europe Thyroid Cancer Diagnostic Market Size by Country (2025-2030)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Thyroid Cancer Diagnostic Market Size (2019-2030)
    8.2 Asia-Pacific Thyroid Cancer Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
    8.3 Asia-Pacific Thyroid Cancer Diagnostic Market Size by Region (2019-2024)
    8.4 Asia-Pacific Thyroid Cancer Diagnostic Market Size by Region (2025-2030)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Thyroid Cancer Diagnostic Market Size (2019-2030)
    9.2 Latin America Thyroid Cancer Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
    9.3 Latin America Thyroid Cancer Diagnostic Market Size by Country (2019-2024)
    9.4 Latin America Thyroid Cancer Diagnostic Market Size by Country (2025-2030)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Thyroid Cancer Diagnostic Market Size (2019-2030)
    10.2 Middle East & Africa Thyroid Cancer Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
    10.3 Middle East & Africa Thyroid Cancer Diagnostic Market Size by Country (2019-2024)
    10.4 Middle East & Africa Thyroid Cancer Diagnostic Market Size by Country (2025-2030)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Detail
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Thyroid Cancer Diagnostic Introduction
        11.1.4 Abbott Revenue in Thyroid Cancer Diagnostic Business (2019-2024)
        11.1.5 Abbott Recent Development
    11.2 Roche
        11.2.1 Roche Company Detail
        11.2.2 Roche Business Overview
        11.2.3 Roche Thyroid Cancer Diagnostic Introduction
        11.2.4 Roche Revenue in Thyroid Cancer Diagnostic Business (2019-2024)
        11.2.5 Roche Recent Development
    11.3 Thermo Fisher Scientific
        11.3.1 Thermo Fisher Scientific Company Detail
        11.3.2 Thermo Fisher Scientific Business Overview
        11.3.3 Thermo Fisher Scientific Thyroid Cancer Diagnostic Introduction
        11.3.4 Thermo Fisher Scientific Revenue in Thyroid Cancer Diagnostic Business (2019-2024)
        11.3.5 Thermo Fisher Scientific Recent Development
    11.4 Siemens Healthcare GmbH
        11.4.1 Siemens Healthcare GmbH Company Detail
        11.4.2 Siemens Healthcare GmbH Business Overview
        11.4.3 Siemens Healthcare GmbH Thyroid Cancer Diagnostic Introduction
        11.4.4 Siemens Healthcare GmbH Revenue in Thyroid Cancer Diagnostic Business (2019-2024)
        11.4.5 Siemens Healthcare GmbH Recent Development
    11.5 Bio-Rad Laboratories
        11.5.1 Bio-Rad Laboratories Company Detail
        11.5.2 Bio-Rad Laboratories Business Overview
        11.5.3 Bio-Rad Laboratories Thyroid Cancer Diagnostic Introduction
        11.5.4 Bio-Rad Laboratories Revenue in Thyroid Cancer Diagnostic Business (2019-2024)
        11.5.5 Bio-Rad Laboratories Recent Development
    11.6 General Electric
        11.6.1 General Electric Company Detail
        11.6.2 General Electric Business Overview
        11.6.3 General Electric Thyroid Cancer Diagnostic Introduction
        11.6.4 General Electric Revenue in Thyroid Cancer Diagnostic Business (2019-2024)
        11.6.5 General Electric Recent Development
    11.7 Koninklijke Philips
        11.7.1 Koninklijke Philips Company Detail
        11.7.2 Koninklijke Philips Business Overview
        11.7.3 Koninklijke Philips Thyroid Cancer Diagnostic Introduction
        11.7.4 Koninklijke Philips Revenue in Thyroid Cancer Diagnostic Business (2019-2024)
        11.7.5 Koninklijke Philips Recent Development
    11.8 Agilent Technologies
        11.8.1 Agilent Technologies Company Detail
        11.8.2 Agilent Technologies Business Overview
        11.8.3 Agilent Technologies Thyroid Cancer Diagnostic Introduction
        11.8.4 Agilent Technologies Revenue in Thyroid Cancer Diagnostic Business (2019-2024)
        11.8.5 Agilent Technologies Recent Development
    11.9 Illumina
        11.9.1 Illumina Company Detail
        11.9.2 Illumina Business Overview
        11.9.3 Illumina Thyroid Cancer Diagnostic Introduction
        11.9.4 Illumina Revenue in Thyroid Cancer Diagnostic Business (2019-2024)
        11.9.5 Illumina Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Table of Figures

List of Tables
    Table 1. Global Thyroid Cancer Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Papillary Carcinoma
    Table 3. Key Players of Follicular Carcinoma
    Table 4. Key Players of Others
    Table 5. Global Thyroid Cancer Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Thyroid Cancer Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Thyroid Cancer Diagnostic Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Thyroid Cancer Diagnostic Market Share by Region (2019-2024)
    Table 9. Global Thyroid Cancer Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Thyroid Cancer Diagnostic Market Share by Region (2025-2030)
    Table 11. Thyroid Cancer Diagnostic Market Trends
    Table 12. Thyroid Cancer Diagnostic Market Drivers
    Table 13. Thyroid Cancer Diagnostic Market Challenges
    Table 14. Thyroid Cancer Diagnostic Market Restraints
    Table 15. Global Thyroid Cancer Diagnostic Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Thyroid Cancer Diagnostic Market Share by Players (2019-2024)
    Table 17. Global Top Thyroid Cancer Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thyroid Cancer Diagnostic as of 2023)
    Table 18. Ranking of Global Top Thyroid Cancer Diagnostic Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by Thyroid Cancer Diagnostic Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Thyroid Cancer Diagnostic Product Solution and Service
    Table 22. Date of Enter into Thyroid Cancer Diagnostic Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Thyroid Cancer Diagnostic Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Thyroid Cancer Diagnostic Revenue Market Share by Type (2019-2024)
    Table 26. Global Thyroid Cancer Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Thyroid Cancer Diagnostic Revenue Market Share by Type (2025-2030)
    Table 28. Global Thyroid Cancer Diagnostic Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Thyroid Cancer Diagnostic Revenue Market Share by Application (2019-2024)
    Table 30. Global Thyroid Cancer Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Thyroid Cancer Diagnostic Revenue Market Share by Application (2025-2030)
    Table 32. North America Thyroid Cancer Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America Thyroid Cancer Diagnostic Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America Thyroid Cancer Diagnostic Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe Thyroid Cancer Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe Thyroid Cancer Diagnostic Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe Thyroid Cancer Diagnostic Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific Thyroid Cancer Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific Thyroid Cancer Diagnostic Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific Thyroid Cancer Diagnostic Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America Thyroid Cancer Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America Thyroid Cancer Diagnostic Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America Thyroid Cancer Diagnostic Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa Thyroid Cancer Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa Thyroid Cancer Diagnostic Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa Thyroid Cancer Diagnostic Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Abbott Company Detail
    Table 48. Abbott Business Overview
    Table 49. Abbott Thyroid Cancer Diagnostic Product
    Table 50. Abbott Revenue in Thyroid Cancer Diagnostic Business (2019-2024) & (US$ Million)
    Table 51. Abbott Recent Development
    Table 52. Roche Company Detail
    Table 53. Roche Business Overview
    Table 54. Roche Thyroid Cancer Diagnostic Product
    Table 55. Roche Revenue in Thyroid Cancer Diagnostic Business (2019-2024) & (US$ Million)
    Table 56. Roche Recent Development
    Table 57. Thermo Fisher Scientific Company Detail
    Table 58. Thermo Fisher Scientific Business Overview
    Table 59. Thermo Fisher Scientific Thyroid Cancer Diagnostic Product
    Table 60. Thermo Fisher Scientific Revenue in Thyroid Cancer Diagnostic Business (2019-2024) & (US$ Million)
    Table 61. Thermo Fisher Scientific Recent Development
    Table 62. Siemens Healthcare GmbH Company Detail
    Table 63. Siemens Healthcare GmbH Business Overview
    Table 64. Siemens Healthcare GmbH Thyroid Cancer Diagnostic Product
    Table 65. Siemens Healthcare GmbH Revenue in Thyroid Cancer Diagnostic Business (2019-2024) & (US$ Million)
    Table 66. Siemens Healthcare GmbH Recent Development
    Table 67. Bio-Rad Laboratories Company Detail
    Table 68. Bio-Rad Laboratories Business Overview
    Table 69. Bio-Rad Laboratories Thyroid Cancer Diagnostic Product
    Table 70. Bio-Rad Laboratories Revenue in Thyroid Cancer Diagnostic Business (2019-2024) & (US$ Million)
    Table 71. Bio-Rad Laboratories Recent Development
    Table 72. General Electric Company Detail
    Table 73. General Electric Business Overview
    Table 74. General Electric Thyroid Cancer Diagnostic Product
    Table 75. General Electric Revenue in Thyroid Cancer Diagnostic Business (2019-2024) & (US$ Million)
    Table 76. General Electric Recent Development
    Table 77. Koninklijke Philips Company Detail
    Table 78. Koninklijke Philips Business Overview
    Table 79. Koninklijke Philips Thyroid Cancer Diagnostic Product
    Table 80. Koninklijke Philips Revenue in Thyroid Cancer Diagnostic Business (2019-2024) & (US$ Million)
    Table 81. Koninklijke Philips Recent Development
    Table 82. Agilent Technologies Company Detail
    Table 83. Agilent Technologies Business Overview
    Table 84. Agilent Technologies Thyroid Cancer Diagnostic Product
    Table 85. Agilent Technologies Revenue in Thyroid Cancer Diagnostic Business (2019-2024) & (US$ Million)
    Table 86. Agilent Technologies Recent Development
    Table 87. Illumina Company Detail
    Table 88. Illumina Business Overview
    Table 89. Illumina Thyroid Cancer Diagnostic Product
    Table 90. Illumina Revenue in Thyroid Cancer Diagnostic Business (2019-2024) & (US$ Million)
    Table 91. Illumina Recent Development
    Table 92. Research Programs/Design for This Report
    Table 93. Key Data Information from Secondary Sources
    Table 94. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Thyroid Cancer Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Thyroid Cancer Diagnostic Market Share by Type: 2023 VS 2030
    Figure 3. Papillary Carcinoma Features
    Figure 4. Follicular Carcinoma Features
    Figure 5. Others Features
    Figure 6. Global Thyroid Cancer Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Thyroid Cancer Diagnostic Market Share by Application: 2023 VS 2030
    Figure 8. Hospital Laboratories Case Studies
    Figure 9. Cancer Diagnostic Centers Case Studies
    Figure 10. Research Institutes Case Studies
    Figure 11. Others Case Studies
    Figure 12. Thyroid Cancer Diagnostic Report Years Considered
    Figure 13. Global Thyroid Cancer Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Thyroid Cancer Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Thyroid Cancer Diagnostic Market Share by Region: 2023 VS 2030
    Figure 16. Global Thyroid Cancer Diagnostic Market Share by Players in 2023
    Figure 17. Global Top Thyroid Cancer Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thyroid Cancer Diagnostic as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Thyroid Cancer Diagnostic Revenue in 2023
    Figure 19. North America Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Thyroid Cancer Diagnostic Market Share by Country (2019-2030)
    Figure 21. United States Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Thyroid Cancer Diagnostic Market Share by Country (2019-2030)
    Figure 25. Germany Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. France Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. U.K. Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Italy Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Russia Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Nordic Countries Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Thyroid Cancer Diagnostic Market Share by Region (2019-2030)
    Figure 33. China Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Japan Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. South Korea Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Southeast Asia Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. India Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Australia Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Thyroid Cancer Diagnostic Market Share by Country (2019-2030)
    Figure 41. Mexico Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Brazil Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Thyroid Cancer Diagnostic Market Share by Country (2019-2030)
    Figure 45. Turkey Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Saudi Arabia Thyroid Cancer Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Abbott Revenue Growth Rate in Thyroid Cancer Diagnostic Business (2019-2024)
    Figure 48. Roche Revenue Growth Rate in Thyroid Cancer Diagnostic Business (2019-2024)
    Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Thyroid Cancer Diagnostic Business (2019-2024)
    Figure 50. Siemens Healthcare GmbH Revenue Growth Rate in Thyroid Cancer Diagnostic Business (2019-2024)
    Figure 51. Bio-Rad Laboratories Revenue Growth Rate in Thyroid Cancer Diagnostic Business (2019-2024)
    Figure 52. General Electric Revenue Growth Rate in Thyroid Cancer Diagnostic Business (2019-2024)
    Figure 53. Koninklijke Philips Revenue Growth Rate in Thyroid Cancer Diagnostic Business (2019-2024)
    Figure 54. Agilent Technologies Revenue Growth Rate in Thyroid Cancer Diagnostic Business (2019-2024)
    Figure 55. Illumina Revenue Growth Rate in Thyroid Cancer Diagnostic Business (2019-2024)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed

Description

Thyroid cancer is a type of cancer that occurs when abnormal cell begin to grow in thyroid gland, responsible for the excretion of thyroid hormones. It is asymptotic in early stage and progresses with formation of lump in thyroid gland. If diagnosed in early stage it can be treated easily.

The global Thyroid Cancer Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Thyroid Cancer Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Industry: Service & Software

Published: 2024-02-07

Pages: 78 Pages

Report ld: 2452676

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 2900.00

Multi Users License

USD 4350.00

Corporate Users License